From: Pathogenic bacteria distributions and drug resistance analysis in 96 cases of neonatal sepsis
E. coli | Klebsiella pneumoniae subsp. | Others | Sum | |
---|---|---|---|---|
Gentamicin | 33.3 (2/6) | 40.0 (4/10) | 66.7 (2/3) | 42.1 (8/19) |
SMZ | 66.7 (4/6) | 50.0 (5/10) | 33.3 (1/3) | 52.6 (10/19) |
Amoxicillin | 83.3 (5/6) | 100.0 (7/7) | 100.0 (2/2) | 93.3 (14/15) |
Piperacillin | 50.0 (3/6) | 100.0 (7/7)a | 66.7 (2/3) | 75.0 (12/16) |
Piperacillin/Tazobactam | 16.7 (1/6) | 80.0 (8/10) | 100.0 (2/2)a | 61.1 (11/18) |
Cefoxitin | 33.3 (2/6) | 100.0 (7/7)a | 100.0 (2/2)a | 73.3 (11/15) |
Ceftazidime | 33.3 (2/6) | 100.0 (10/10) | 66.7 (2/3) | 73.7 (14/19) |
Cefepime | 33.3 (2/6) | 100.0 (10/10) | 66.7 (2/3) | 73.7 (14/19) |
Cefuroxime | 50.0 (3/6) | 100.0 (7/7) | 66.7 (2/3) | 75.0 (12/16) |
Meropenem | 0.0 (0/6) | 0.0 (0/7)a | 50.0 (1/2)a | 6.7 (1/15) |
Imipenem | 0.0 (0/6) | 30.0 (3/10) | 33.3 (1/3) | 21.1 (4/19) |
Amikacin | 0.0 (0/6) | 0.0 (0/10) | 0.0 (0/3) | 0.0 (0/19) |
Amoxicillin/clavulanate | 33.3 (2/6) | 100.0 (7/7)a | 100.0 (2/2)a | 73.3 (11/15) |
Cefalotin | 50.0 (3/6) | 70.0 (7/10) | 100.0 (2/2)a | 66.7 (12/18) |
Cefotaxime | 33.3 (2/6) | 100.0 (7/7)a | 66.7 (2/3) | 68.8 (11/16) |
Tobramycin | 50.0 (3/6) | 10.0 (1/10) | 100.0 (2/2) | 33.3 (6/18) |